| High levels of latent antithrombin in plasma from patients with antithrombin deficiency M de la Morena-Barrio, E Sandoval, P Llamas, E Wypasek, M Toderici, ... Thrombosis and haemostasis 117 (05), 880-888, 2017 | 27 | 2017 |
| Genetic predisposition to fetal alcohol syndrome: association with congenital disorders of N-glycosylation ME de la Morena-Barrio, MJ Ballesta-Martínez, R López-Gálvez, AI Antón, ... Pediatric Research 83 (1), 119-127, 2018 | 20 | 2018 |
| Defects of splicing in antithrombin deficiency ME de la Morena‐Barrio, R López‐Gálvez, I Martínez‐Martínez, S Asenjo, ... Research and Practice in Thrombosis and Haemostasis 1 (2), 216-222, 2017 | 13 | 2017 |
| Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway R López-Gálvez, ME de la Morena-Barrio, A López-Lera, M Pathak, ... Orphanet Journal of Rare Diseases 15, 1-10, 2020 | 12 | 2020 |
| Non-vitamin K antagonist oral anticoagulants and drug-food interactions: implications for clinical practice and potential role of probiotics and prebiotics A Sanchez-Fuentes, JM Rivera-Caravaca, R Lopez-Galvez, F Marin, ... Frontiers in Cardiovascular Medicine 8, 787235, 2022 | 11 | 2022 |
| Airway Administration of Flagellin Regulates the Inflammatory Response to Pseudomonas aeruginosa R López-Gálvez, I Fleurot, P Chamero, S Trapp, M Olivier, C Chevaleyre, ... American Journal of Respiratory Cell and Molecular Biology 65 (4), 378-389, 2021 | 11 | 2021 |
| Cerebrovascular, cognitive and cardiac benefits of SGLT2 inhibitors therapy in patients with atrial fibrillation and type 2 diabetes mellitus: results from a global federated … R Proietti, JM Rivera-Caravaca, R López-Gálvez, SL Harrison, F Marín, ... Journal of Clinical Medicine 12 (8), 2814, 2023 | 6 | 2023 |
| Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study R López‐Gálvez, JM Rivera‐Caravaca, M Anguita Sánchez, ... European Journal of Clinical Investigation 52 (9), e13788, 2022 | 6 | 2022 |
| Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making R Lopez-Galvez, JM Rivera-Caravaca, V Roldan, E Orenes-Pinero, ... American Heart Journal 258, 1-16, 2023 | 5 | 2023 |
| Relation of the ‘Atrial fibrillation Better Care (ABC) Pathway’to the quality of anticoagulation in atrial fibrillation patients taking vitamin K antagonists V Roldan, L Martinez-Montesinos, R Lopez-Galvez, L Garcia-Tomas, ... Journal of Personalized Medicine 12 (3), 487, 2022 | 5 | 2022 |
| TLR5 signalling is hyper-responsive in porcine cystic fibrosis airways epithelium I Fleurot, R López-Gálvez, P Barbry, A Guillon, M Si-Tahar, A Bähr, ... Journal of Cystic Fibrosis 21 (2), e117-e121, 2022 | 5 | 2022 |
| Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review D Mandaglio-Collados, R López-Gálvez, AJ Ruiz-Alcaraz, ... Science of the Total Environment 880, 163352, 2023 | 4 | 2023 |
| Transient desialylation in combination with a novel antithrombin deficiency causing a severe and recurrent thrombosis despite anticoagulation therapy N Revilla, ME de La Morena-Barrio, A Miñano, R López-Gálvez, ... Scientific Reports 7 (1), 44556, 2017 | 4 | 2017 |
| Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea R López‐Gálvez, JM Rivera‐Caravaca, D Mandaglio‐Collados, ... The FASEB Journal 37 (6), e22941, 2023 | 3 | 2023 |
| A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA … MA Esteve-Pastor, JM Rivera-Caravaca, M Ruiz-Ortiz, J Muñiz, ... Expert Opinion on Pharmacotherapy 23 (12), 1457-1465, 2022 | 3 | 2022 |
| Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis R Proietti, JM Rivera‐Caravaca, R López‐Gálvez, SL Harrison, ... Clinical cardiology 46 (6), 656-662, 2023 | 2 | 2023 |
| Growth differentiation factor 15 in cardiovascular diseases: predicting bleeding after cardiac surgery and beyond that! R López-Gálvez, JM Rivera-Caravaca Thrombosis and Haemostasis 122 (05), 657-660, 2022 | 2 | 2022 |
| Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 P.Thr309Lys Variant R López-Gálvez, ME de la Morena-Barrio, A Miñano, M Pathak, C Marcos, ... Clinical reviews in allergy & immunology 60, 357-368, 2021 | 2 | 2021 |
| Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients MV Porlán, A Tello-Montoliu, C López-García, P Gil-Pérez, ... IJC Heart & Vasculature 46, 101195, 2023 | 1 | 2023 |
| Multimorbidity, frailty and malnutrition: moving beyond traditional risk factors for risk assessment in atrial fibrillation. The Murcia Atrial Fibrillation Project II JM Rivera-Caravaca, B Zazo-Luengo, L Martinez-Montesinos, ... European Heart Journal 43 (Supplement_2), ehac544. 635, 2022 | 1 | 2022 |
